volume 49 issue 1 pages 51-69

Matrix Metalloproteinase Target Family Landscape:  A Chemometrical Approach to Ligand Selectivity Based on Protein Binding Site Analysis

B. Pirard 1
HANS C. MATTER 1
1
 
Science and Medical Affairs, Chemical Sciences, Drug Design, Aventis Pharma Deutschland GmbH, a Company of the Sanofi-Aventis Group, D-65926 Frankfurt am Main, Germany
Publication typeJournal Article
Publication date2005-11-17
scimago Q1
wos Q1
SJR1.801
CiteScore11.5
Impact factor6.8
ISSN00222623, 15204804
PubMed ID:  16392792
Drug Discovery
Molecular Medicine
Abstract
To gain insight into the structural determinants for the matrix metalloproteinase (MMP) family, we characterized the binding sites of 56 MMP structures and one TACE (tumor necrosis factor alpha converting enzyme) structure using molecular interaction fields (MIFs). These MIFs were produced by two approaches: the GRID force field and the knowledge-based potential DrugScore. The subsequent statistical analysis using consensus principal component analysis (CPCA) for the entire binding site and each subpockets revealed both approaches to encode similar information about discriminating regions. However, the relative importance of the probes varied between both approaches. The CPCA models provided the following ranking of the six subpockets based on the opportunity for selective interactions with different MMPs: S1' > S2, S3, S3' > S1, S2'. The interpretation of these models agreed with experimental binding modes inferred from crystal structures or docking.
Found 
Found 

Top-30

Journals

1
2
3
4
Journal of Medicinal Chemistry
4 publications, 7.41%
Bioorganic and Medicinal Chemistry
3 publications, 5.56%
Журнал Общей Химии
3 publications, 5.56%
Chemical Communications
2 publications, 3.7%
Russian Journal of General Chemistry
2 publications, 3.7%
Expert Opinion on Drug Discovery
2 publications, 3.7%
Biological Chemistry
2 publications, 3.7%
Current Topics in Medicinal Chemistry
1 publication, 1.85%
Porto Biomedical Journal
1 publication, 1.85%
Future Medicinal Chemistry
1 publication, 1.85%
Cancer and Metastasis Reviews
1 publication, 1.85%
Drugs
1 publication, 1.85%
BMC Bioinformatics
1 publication, 1.85%
Pharmaceutical Chemistry Journal
1 publication, 1.85%
Bioorganic and Medicinal Chemistry Letters
1 publication, 1.85%
Computational Biology and Chemistry
1 publication, 1.85%
Current Opinion in Chemical Biology
1 publication, 1.85%
European Journal of Medicinal Chemistry
1 publication, 1.85%
Chemometrics and Intelligent Laboratory Systems
1 publication, 1.85%
Enzyme and Microbial Technology
1 publication, 1.85%
Journal of Molecular Graphics and Modelling
1 publication, 1.85%
Journal of Biological Chemistry
1 publication, 1.85%
Biochimica et Biophysica Acta - Molecular Cell Research
1 publication, 1.85%
European Journal of Pharmacology
1 publication, 1.85%
Molecular Immunology
1 publication, 1.85%
ChemistrySelect
1 publication, 1.85%
Angewandte Chemie
1 publication, 1.85%
Angewandte Chemie - International Edition
1 publication, 1.85%
ChemMedChem
1 publication, 1.85%
1
2
3
4

Publishers

2
4
6
8
10
12
14
Elsevier
13 publications, 24.07%
Wiley
8 publications, 14.81%
American Chemical Society (ACS)
8 publications, 14.81%
Springer Nature
5 publications, 9.26%
Royal Society of Chemistry (RSC)
4 publications, 7.41%
Taylor & Francis
3 publications, 5.56%
Pleiades Publishing
3 publications, 5.56%
Walter de Gruyter
2 publications, 3.7%
The Russian Academy of Sciences
2 publications, 3.7%
Bentham Science Publishers Ltd.
1 publication, 1.85%
Ovid Technologies (Wolters Kluwer Health)
1 publication, 1.85%
American Society for Biochemistry and Molecular Biology
1 publication, 1.85%
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 1.85%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 1.85%
2
4
6
8
10
12
14
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
54
Share
Cite this
GOST |
Cite this
GOST Copy
Pirard B., MATTER H. C. Matrix Metalloproteinase Target Family Landscape: A Chemometrical Approach to Ligand Selectivity Based on Protein Binding Site Analysis // Journal of Medicinal Chemistry. 2005. Vol. 49. No. 1. pp. 51-69.
GOST all authors (up to 50) Copy
Pirard B., MATTER H. C. Matrix Metalloproteinase Target Family Landscape: A Chemometrical Approach to Ligand Selectivity Based on Protein Binding Site Analysis // Journal of Medicinal Chemistry. 2005. Vol. 49. No. 1. pp. 51-69.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/jm050363f
UR - https://doi.org/10.1021/jm050363f
TI - Matrix Metalloproteinase Target Family Landscape: A Chemometrical Approach to Ligand Selectivity Based on Protein Binding Site Analysis
T2 - Journal of Medicinal Chemistry
AU - Pirard, B.
AU - MATTER, HANS C.
PY - 2005
DA - 2005/11/17
PB - American Chemical Society (ACS)
SP - 51-69
IS - 1
VL - 49
PMID - 16392792
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2005_Pirard,
author = {B. Pirard and HANS C. MATTER},
title = {Matrix Metalloproteinase Target Family Landscape: A Chemometrical Approach to Ligand Selectivity Based on Protein Binding Site Analysis},
journal = {Journal of Medicinal Chemistry},
year = {2005},
volume = {49},
publisher = {American Chemical Society (ACS)},
month = {nov},
url = {https://doi.org/10.1021/jm050363f},
number = {1},
pages = {51--69},
doi = {10.1021/jm050363f}
}
MLA
Cite this
MLA Copy
Pirard, B., and HANS C. MATTER. “Matrix Metalloproteinase Target Family Landscape: A Chemometrical Approach to Ligand Selectivity Based on Protein Binding Site Analysis.” Journal of Medicinal Chemistry, vol. 49, no. 1, Nov. 2005, pp. 51-69. https://doi.org/10.1021/jm050363f.